This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Plexus Announces Expansion And SFDA Certification In Xiamen, China

NEENAH, Wis., Dec. 9, 2010 (GLOBE NEWSWIRE) -- Plexus Corp. (Nasdaq:PLXS) announced today that it has entered into an agreement to purchase land for the construction of a new manufacturing facility in the Xiamen Xiangyu Free Trade Zone, adjacent to its current facility. This new facility will operate under the existing management team and will add approximately 180,000 square feet of manufacturing capacity. Construction is expected to begin in March 2011 with production to commence in the second half of calendar 2012. In addition, Plexus' current Xiamen, China manufacturing facility has received State Food and Drug Administration, P.R. China (SFDA) certification to support customers in the Medical industries. This certification allows Plexus to manufacture finished Class I and II medical devices for our customers that sell into China end-markets. 

Mr. YJ Lim, Regional President-Plexus Asia Pacific, commented, "This facility investment is the result of strong organic growth for Plexus in the Asia Pacific region and continues our strategy of investing in close proximity to current locations to leverage our strong operations teams. With the support of our local supply chain partners, our manufacturing capabilities offer a significant advantage for companies that are seeking mid-to-low volume, higher complexity Product Realization Value Stream Solutions in China." 

Mr. Lim continued, "The SFDA certification in our Xiamen facility will allow us to further enhance our Medical service offerings to global customers seeking end-market fulfillment of medical products into China. We are excited about the opportunity this provides for us to expand our reach in the People's Republic of China, a growing medical device market."

The expanded Xiamen facility will continue to focus on the Medical, Industrial/Commercial and Wireline/Networking market sectors. Most recently the Plexus Xiamen facility was awarded the Xiamen Top 100 Enterprise and Top 10 Return on Capital Employed Enterprise by Xiamen Enterprise Association.

About Plexus Corp. – The Product Realization Company

Plexus ( www.plexus.com ) delivers optimized Product Realization solutions through a unique Product Realization Value Stream service model.  This customer focused services model seamlessly integrates innovative product conceptualization, design, commercialization, manufacturing, fulfillment, and sustaining services to deliver comprehensive end-to-end solutions for customers in the North American, European and Asia-Pacific regions. 

Plexus is the industry leader in servicing mid-to-low volume, higher complexity customer programs characterized by unique flexibility, technology, quality and regulatory requirements. Award-winning customer service is provided to over 100 branded product companies in the Wireline/Networking, Wireless Infrastructure, Medical, Industrial/Commercial and Defense/Security/Aerospace market sectors.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs